Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H FLEISCH

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
Journal of Pharmacological Methods|August 1, 1981
Schultz-Dale reaction in mouse tracheaG A Koppel, K D Haisch, S M Spaethe, et al.
Journal of Medicinal Chemistry|April 3, 1992
Optimization of the quinoline and substituted benzyl moieties of a series of phenyltetrazole leukotriene D4 receptor antagonistsJ S Sawyer, R F Baldwin, L E Rinkema, et al.
Agents and Actions|August 1, 1987
Structure-activity relationships (SAR) of the 3-alkyl substituents among a series of hydroxy-acetophenone leukotriene antagonistsW S Marshall, C A Whitesitt, T Goodson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphateM J Schmidt, B D Sawyer, L L Truex, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1993
Contraction of guinea pig inferior vena cava by eicosanoidsL E Rinkema, C R Roman, E L VanAlstyne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionR C Mühlbauer, F Bauss, R Schenk, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1994
Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the ratC D Egger, R C Mühlbauer, R Felix, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1986
Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4J H Fleisch, L E Rinkema, K D Haisch, et al.
Endocrinology|January 1, 1992
Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorptionV A Corboz, M G Cecchini, R Felix, et al.
Journal of Medicinal Chemistry|May 1, 1987
Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivativesR D Dillard, F P Carr, D McCullough, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Journal of Pharmacological Methods|August 1, 1981
Schultz-Dale reaction in mouse tracheaG A Koppel, K D Haisch, S M Spaethe, et al.
Journal of Medicinal Chemistry|April 3, 1992
Optimization of the quinoline and substituted benzyl moieties of a series of phenyltetrazole leukotriene D4 receptor antagonistsJ S Sawyer, R F Baldwin, L E Rinkema, et al.
Agents and Actions|August 1, 1987
Structure-activity relationships (SAR) of the 3-alkyl substituents among a series of hydroxy-acetophenone leukotriene antagonistsW S Marshall, C A Whitesitt, T Goodson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphateM J Schmidt, B D Sawyer, L L Truex, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1993
Contraction of guinea pig inferior vena cava by eicosanoidsL E Rinkema, C R Roman, E L VanAlstyne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionR C Mühlbauer, F Bauss, R Schenk, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1994
Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the ratC D Egger, R C Mühlbauer, R Felix, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1986
Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4J H Fleisch, L E Rinkema, K D Haisch, et al.
Endocrinology|January 1, 1992
Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorptionV A Corboz, M G Cecchini, R Felix, et al.
Journal of Medicinal Chemistry|May 1, 1987
Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivativesR D Dillard, F P Carr, D McCullough, et al.
Pageof 22